The AI for Oncology Conference aims to equip participants with a comprehensive understanding of how advanced AI technologies are transforming cancer care and research. As AI innovation accelerates, its applications in oncology are becoming essential across the spectrum of diagnosis, treatment, and research. From integrating diverse datasets, such as multiomics, imaging, and clinical data, to advancing diagnostic precision, AI is enabling the discovery of patterns that traditional methods often overlook.
Participants will explore how AI-driven platforms are improving the integration of data, leading to more accurate diagnostics and personalized treatment approaches for cancers such as lung, breast, and colorectal cancers. Innovations in radiomics and digital pathology will also be highlighted, showcasing how AI enhances the analysis of imaging data and histopathology, particularly for challenging cancers like pancreatic, liver, prostate, and head and neck tumors.
The conference will further delve into the role of AI in optimizing clinical research, from designing clinical trials to refining targeted therapies and immunotherapies.
The event will cover two days. The speakers will have a diverse background to reflect the spectrum of Artificial Intelligence research (and beyond), from Artificial Intelligence engineering experts to clinicians and translational researchers and hybrid figures such as clinical Artificial Intelligence specialists. Faculty members represent worldwide centers of excellence in the field. The attendance is expected to mirror this variety, along with participants with a more specific background in imaging and pathology.
The conference also includes poster sessions, with prizes for the best posters in various AI fields. Participants will also be encouraged to participate in a call for abstracts, with the opportunity to present their work in flash talks during the symposium.